MGMT and glioblastoma: Here, we assessed the anti-tumor activity of XH30 in two TMZ-resistant GBM cell lines: one with acquired TMZ resistance and overactivated hedgehog signaling (U251/TMZ) and one with natural TMZ resistance and elevated MGMT levels (T98G).